Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Clinical and laboratory reevalution of dichloromethotrexate.
B. Fernbach
, I. Takahashi
, T. Ohnuma
, J. F. Holland
Icahn School of Medicine at Mount Sinai
Research output
:
Contribution to journal
›
Article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clinical and laboratory reevalution of dichloromethotrexate.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Methotrexate
100%
High Dose
50%
Human Serum Albumin
50%
Tumor
25%
Pharmacologic
25%
Inhibitory Effect
25%
Hematotoxicity
25%
Clinical Effect
25%
Advanced Malignancies
25%
Colon Adenocarcinoma
25%
Dosing Schedule
25%
Hepatic Metastasis
25%
Hepatic Dysfunction
25%
Biologic Effect
25%
In Vitro Comparison
25%
Calcium Folinate
25%
Pharmacologic Effects
25%
Leucovorin Calcium
25%
Plasma Decay
25%
Pharmacology, Toxicology and Pharmaceutical Science
Dichloromethotrexate
100%
Methotrexate
36%
Human Serum Albumin
18%
Folinate Calcium
18%
Neoplasm
9%
Liver Metastasis
9%
Colon Carcinoma
9%
Liver Dysfunction
9%